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The pain phenomena as a disabling state but 
normal fact in human has been noticed to alarm and 
concern to the tissue injury and damage. Pain 
management is one the most worldwide clinical 
challenges in general population that is associated with 
considerable health care expenses, decreased 
productive time and impression on the quality of life. 
Numerous studies have been done to identify its 
pathophysiology and effective therapeutic agents. 
Attention to pain etiology, the relationship of 
inflammatory pathways, the molecular mechanisms 
and involved transmitters have given insights to novel 
approaches with more effective pain relief agents. In 
addition to over the counter analgesic and prescription 
medicine (NSAIDs, opioids, COX-2 inhibitors), there 
is no consensus about the analgesic role of herbal 
medicines. Cochrane library reviewed the place of 
herbal medicine in low back pain. They showed 
although the RCTs were not large trials and well-
designed but herbal medicine could reduce pain more 
than placebo in short term without significant side 
effects (1). 
Lidocaine as local/regional anesthetic agent has 
been introduced to reduce acute postoperative pain, the 
chronic pain conditions, myofascial pain, refractory 
neuropathic pain and neuralgia. In cancer pain patients 
with refractory to opioid agents, lidocaine infusion 
could achieve adequate analgesic state (2). Review of 
literature shows the recovery improvement by 
lidocaine infusion depends to the type of surgery. 
There is strong evidence to decrease pain scores in 
abdominal surgeries (both open and laparoscopy). In 
prostate, breast, thoracic and spine operations, the 
evidence is moderate with small benefit. In cardiac 
surgery, lidocaine infusion would decrease 
postoperative cognitive disorder with no analgesic 
effect (3). 
Lidocaine acts predominantly through blocking 
sodium channels. These channels in cell membrane 
would be upregulated and more excitable in 
neuropathic pain. Moreover lidocaine potentiates the 
ATP production and release of endogenous opioids. It 
has anti-inflammatory properties, reduces the level of 
circulating inflammatory cytokines and inhibits the 
stimulatory amino acids and thromboxane A2. The 
lidocaine metabolite attenuates nociceptive effect by 
increasing glycine level. Intravenous infusion of 
Lidocaine at the time of operation had been proved to 
be analgesic immediately after surgery until 24h later 
with recovery improvement. The low plasma level 
(0.5- 5 µg/ml) is adequate for pain relief with 
reasonable safety profile. Different treatment regimens 
have been described: low vs, high dose (< or > 
2mg/kg/h) and diversity in infusion time (until the end 
of surgery vs, prolonged infusion). Although it is short 
acting but prolonged anesthetic effect has been 
reported even after single treatment. Its analgesic effect 
may be constant for more than 6h and reduced pain 
level for several days. With consideration of short 
biologic half-life it couldn’t be interpreted. The 
analgesic effect is more pronounce in elderly patients 
than young and it is more efficient in more severe pain 
vs. lower intensity pain. The most frequent reported 
adverse effects during lidocaine infusion are: nausea, 
vomiting, lightheadedness, tinnitus, muscle spasm, 
perioral paresthesia and cardiac dysrhythmias. All of 
them would respond to dose reduction. It is 
inexpensive, comparable and as effective as epidural 
catheter without related neurologic complications. 
Although there is no consensus in dosing and infusion 
time, but is suggested to be part of treatment in opioid 
dependent persons (2-6).  
In this issue two pain related articles would be 
discussed:” Potential role of herbal medicine in 
alleviating pain and inflammation in osteoarthritis: A 
review”, and “Effect of intravenous infusion of 
Lidocaine on pain reduction after caesarean section 
under general anesthesia (7, 8). 
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There are well defined strategies to control pain, 
reduce postoperative bleeding and homeostasis 
maintenance. Balancing the homeostasis, correction of 
acid base irregularity, pain management, bleeding 
control and reduction of blood loss during surgery are 
part of the main skills of anesthesiologists. Today 
attention to cellular and molecular aspects of 
mentioned items are the more interesting topics. 
Consideration of molecular basis of these items are the 
main aim of the Journal of Cellular and Molecular 
Anesthesia.  
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